The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
CORONARY INTERVENTIONS
The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study
EuroIntervention 2017;12:1614-1622 published online ahead of print December 2015. DOI: 10.4244/EIJY15M12_02
1. AP-HP, Hôpital Cochin, Service de Cardiologie, Paris, France; 2. Université Paris Descartes, Université Sorbonne Paris Cité, Paris, France; 3. AP-HM, Hôpital de la Timone, Service de Cardiologie, Marseille, France; 4. Générale de Santé, Institut Cardio
Aims: In the elderly population, bare metal stents (BMS) are often preferred over drug-eluting stents (DES) because of the longer duration of dual antiplatelet therapy (DAPT) associated w